Feedback / Questions
prexasertib (ACR-368) - Acrivon Therap
ACR-2316 - Acrivon Therap
https://www.globenewswire.com/en/news-release/2024/05/14/2881340/0/en/Acrivon-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Business-Highlights.html
May 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next